Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09AWJ
|
|||
| Former ID |
DIB004837
|
|||
| Drug Name |
H5N1 influenza vaccine
|
|||
| Synonyms |
IPSIV; Inactivated Polymer-Subunit H5N1 Influenza Vaccine; H5N1 influenza vaccine (protein subunit, Polyoxidonium adjuvant); H5N1 influenza vaccine (protein subunit, Polyoxidonium adjuvant), Microgen
Click to Show/Hide
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Approved | [1] | |
| Company |
Glaxosmithkline; novavax; vaxart
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cell mediated immunity response (CMIR) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of GlaxoSmithKline. | |||
| REF 2 | Comparative clinical trial of vaccines against avian influenza. Zh Mikrobiol Epidemiol Immunobiol. 2007 May-Jun;(3):10-6. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.